No credit card. No commitment.
5000+ G2 reviews
NephroSant, Inc.
Research
Founded in 2017
San Mateo, CaliforniaNephroSant, Inc.
ResearchFounded in 2017San Mateo, California
EmployeesNephroSant, Inc.'s financial review
Employees
6
Total Funding
16M
Last Funding Round
16M
NephroSant, Inc. information
Kidney transplantation is the treatment of choice for patients with end-stage kidney failure. However, the life of a kidney transplant is limited due to unrecognized immune injury. There is no sensitive, non-invasive method to detect this injury at an early-stage. We have developed a reliable, inexpensive, and noninvasive assay to monitor kidney injury.
NephroSant, Inc. industries
Kidney injury
Kidney transplantation
Chronic kidney disease
Kidney health
NephroSant, Inc.'s financial review
Employees
6
Total Funding
16M
Last Funding Round
16M
Employee Metrics
Technologies
Email Providers
Hosting
Fonts
Other
Frameworks and Programming Languages
CMS
Notable Alumni
Jen Coccodrilli
Regional Transplant Manager, MidAtlantic and Northeastern USEurofins Transplant Genomics
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
